The global glaucoma treatment market is expected to grow from USD 7,263.68 million 2017 to USD 11,841.14 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 7.23%.

On the basis of indication, the global glaucoma treatment market is studied across Angle Closure Glaucoma, Congenital Glaucoma, Open Angle Glaucoma, and Secondary Glaucoma.

On the basis of sales channel, the global glaucoma treatment market is studied across Hospital Pharmacies, Online Sales, and Retail Pharmacies.

On the basis of type, the global glaucoma treatment market is studied across Alpha Agonist, Beta Blockers, Carbonic Anhydrase Inhibitors, Cholinergic, Combined Medications, and Prostaglandin Analogs.

On the basis of geography, the global glaucoma treatment market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).

"Aerie Pharmaceuticals: The potential growing player for the global glaucoma treatment market"

The key players profiled in the global glaucoma treatment market are Aerie Pharmaceuticals, Akorn, Inc., Allergan Plc, Bausch & Lomb Incorporated, Merck & Co, Inc., Mobius Therapeutics, LLC, Novartis AG, Ocular Therapeutix, Perrigo Co. Plc, Pfizer, Inc., and Teva Pharmaceutical Industries Limited.


The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global glaucoma treatment market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global glaucoma treatment market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global glaucoma treatment market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global glaucoma treatment market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global glaucoma treatment market.